Fougera Pharmaceuticals Inc.
Records under this name other than patents Fougera Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Fougera Pharmaceuticals Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,858,662 | Medicament for the treatment of viral skin and tumour diseases Formerly held Term ended Term ended Oct 2, 2026 · From the USPTO record | Term ended | Term ended Oct 2, 2026 | From the USPTO record |
| US 9,770,406 | Medicament for the treatment of viral skin and tumour diseases Formerly held Term ended Term ended Jul 12, 2025 · From the USPTO record | Term ended | Term ended Jul 12, 2025 | From the USPTO record |
| US 8,313,756 | Urea Compositions and Their Methods of Manufacture Formerly held Lapsed on the fee record Ended Nov 20, 2024 · High confidence | Lapsed on the fee record | Ended Nov 20, 2024 | High confidence |
| US 8,455,022 | Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin Term ended Term ended Oct 8, 2024 · From the USPTO record | Term ended | Term ended Oct 8, 2024 | From the USPTO record |
| US 8,158,138 | Urea Compositions and Their Methods of Manufacture Lapsed on the fee record Ended Apr 17, 2024 · High confidence | Lapsed on the fee record | Ended Apr 17, 2024 | High confidence |
| US 8,425,474 | Method and Apparatus for Dispensing a Composition Term ended Term ended Mar 14, 2024 · Medium confidence | Term ended | Term ended Mar 14, 2024 | Medium confidence |
| US 9,060,998 | Use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin Lapsed on the fee record Ended Jun 23, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 23, 2023 | From the USPTO record |
| US 7,910,138 | Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin Lapsed on the fee record Ended Mar 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 22, 2023 | From the USPTO record |
| US 7,897,587 | Topical Dermatological Formulations and Use Thereof Lapsed on the fee record Ended Mar 1, 2023 · High confidence | Lapsed on the fee record | Ended Mar 1, 2023 | High confidence |
| US 6,827,943 | Dermatological Composition Containing Urea Term ended Ended no later than Jan 7, 2023 · Medium confidence | Term ended | Ended no later than Jan 7, 2023 | Medium confidence |